Indonesian
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and the Future of Lipid Lowering Therapy
Overview of attention for article published in Progress in Cardiovascular Diseases, May 2015
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (84th percentile)
-
Above-average Attention Score compared to outputs of the same age and source (60th percentile)
Readers on
- mendeley
- 91 Mendeley